Hyperforin dicyclohexylammonium salt is primarily utilized in research and development within the field of pharmacology and neuroscience. Its application is centered around studying its potential effects on neurotransmitter systems, particularly its role in modulating synaptic plasticity and neuronal signaling. Researchers investigate its properties to explore its therapeutic potential in treating mood disorders, such as depression and anxiety, due to its interaction with key receptors and ion channels in the brain. Additionally, it is used in experimental studies to understand its anti-inflammatory and neuroprotective mechanisms, which could have implications for neurodegenerative diseases. The compound is also employed in the development of novel drug formulations aimed at enhancing bioavailability and efficacy in targeted therapies.